Literature DB >> 34099494

A Wnt-Independent LGR4-EGFR Signaling Axis in Cancer Metastasis.

Fei Yue1, Weiyu Jiang1, Amy T Ku1, Adelaide I J Young1, Weijie Zhang1, Eric P Souto1, Yankun Gao2, Zihan Yu2, Yi Wang2, Chad J Creighton3,4, Chandandeep Nagi1,5, Tao Wang4, Susan G Hilsenbeck1,4, Xin-Hua Feng6,7,8, Shixia Huang4,6, Cristian Coarfa3,6,9, Xiang H-F Zhang1,4,6,10, Qingyun Liu11, Xia Lin7, Yi Li12,4,6,13.   

Abstract

Leucine-rich repeat-containing G protein-coupled receptors 4, 5, and 6 (LGR4/5/6) play critical roles in development and cancer. The widely accepted mechanism is that these proteins, together with their R-spondin ligands, stabilize Wnt receptors, thus potentiating Wnt signaling. Here we show that LGR4 enhanced breast cancer cell metastasis even when Wnt signaling was deactivated pharmacologically or genetically. Furthermore, LGR4 mutants that cannot potentiate Wnt signaling nevertheless promoted breast cancer cell migration and invasion in vitro and breast cancer metastasis in vivo. Multiomic screening identified EGFR as a crucial mediator of LGR4 activity in cancer progression. Mechanistically, LGR4 interacted with EGFR and blocked EGFR ubiquitination and degradation, resulting in persistent EGFR activation. Together, these data uncover a Wnt-independent LGR4-EGFR signaling axis with broad implications for cancer progression and targeted therapy. SIGNIFICANCE: This work demonstrates a Wnt-independent mechanism by which LGR4 promotes cancer metastasis.See related commentary by Stevens and Williams, p. 4397. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34099494      PMCID: PMC8416783          DOI: 10.1158/0008-5472.CAN-21-1112

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  65 in total

1.  Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Authors:  Xiang H-F Zhang; Xin Jin; Srinivas Malladi; Yilong Zou; Yong H Wen; Edi Brogi; Marcel Smid; John A Foekens; Joan Massagué
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Unlike LGR4, LGR5 potentiates Wnt-β-catenin signaling without sequestering E3 ligases.

Authors:  Soohyun Park; Ling Wu; Jianghua Tu; Wangsheng Yu; Yukimatsu Toh; Kendra S Carmon; Qingyun J Liu
Journal:  Sci Signal       Date:  2020-12-01       Impact factor: 8.192

3.  GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.

Authors:  Jinhua Wu; Na Xie; Ke Xie; Jun Zeng; Lin Cheng; Yunlong Lei; Yuan Liu; Linhong Song; Dandan Dong; Yi Chen; Rui Zeng; Edouard C Nice; Canhua Huang; Yuquan Wei
Journal:  Carcinogenesis       Date:  2013-06-26       Impact factor: 4.944

4.  beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.

Authors:  J S Michaelson; P Leder
Journal:  Oncogene       Date:  2001-08-23       Impact factor: 9.867

5.  Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.

Authors:  Bon-Kyoung Koo; Maureen Spit; Ingrid Jordens; Teck Y Low; Daniel E Stange; Marc van de Wetering; Johan H van Es; Shabaz Mohammed; Albert J R Heck; Madelon M Maurice; Hans Clevers
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

6.  Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension.

Authors:  Hiroki Morita; Sabine Mazerbourg; Donna M Bouley; Ching-Wei Luo; Kazuhiro Kawamura; Yoshimitsu Kuwabara; Helene Baribault; Hui Tian; Aaron J W Hsueh
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.

Authors:  Ying Wang; Jie Dong; Dali Li; Li Lai; Stefan Siwko; Yi Li; Mingyao Liu
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

8.  The epidermal growth factor receptor is covalently linked to ubiquitin.

Authors:  Z Galcheva-Gargova; S J Theroux; R J Davis
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

9.  Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.

Authors:  Weijia Luo; Peng Tan; Melissa Rodriguez; Lian He; Kunrong Tan; Li Zeng; Stefan Siwko; Mingyao Liu
Journal:  J Biol Chem       Date:  2017-08-02       Impact factor: 5.157

10.  R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5.

Authors:  Heinz Ruffner; Joëlle Sprunger; Olga Charlat; Juliet Leighton-Davies; Bianka Grosshans; Adrian Salathe; Svenja Zietzling; Valérie Beck; Maxime Therier; Andrea Isken; Yang Xie; Yue Zhang; Huaixiang Hao; Xiaoying Shi; Dong Liu; Qinhui Song; Ieuan Clay; Gabriele Hintzen; Jan Tchorz; Laure C Bouchez; Gregory Michaud; Peter Finan; Vic E Myer; Tewis Bouwmeester; Jeff Porter; Marc Hild; Fred Bassilana; Christian N Parker; Feng Cong
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

View more
  2 in total

1.  STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential.

Authors:  Meng Lin; Amy T Ku; Jie Dong; Fei Yue; Weiyu Jiang; Ahmed Atef Ibrahim; Fanglue Peng; Chad J Creighton; Chandandeep Nagi; Carolina Gutierrez; Jeffrey M Rosen; Xiang H-F Zhang; Susan G Hilsenbeck; Xi Chen; Yi-Chieh Nancy Du; Shixia Huang; Aiping Shi; Zhimin Fan; Yi Li
Journal:  Oncogene       Date:  2022-10-19       Impact factor: 8.756

Review 2.  Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis.

Authors:  Linlin Yang; Jing Wang; Xiaodi Gong; Qiong Fan; Xiaoming Yang; Yunxia Cui; Xiaoyan Gao; Lijuan Li; Xiao Sun; Yuhong Li; Yudong Wang
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.